| Dr Peter Eric Boehm Sr, MD | |
|
1010 E 3rd St Ste 202, Chattanooga, TN 37403-2174 | |
| (423) 265-2233 | |
| (423) 756-8265 |
| Full Name | Dr Peter Eric Boehm Sr |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 54 Years |
| Location | 1010 E 3rd St Ste 202, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467542449 | NPI | - | NPPES |
| 130010570 | Other | TN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD7007 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chattanooga Hamilton County Hospital Authority | 0547179731 | 156 |
| Erlanger Health | 1153780226 | 352 |
News Archive
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed a clay-based platform to deliver therapeutic proteins to the body to assist with the formation of blood vessels.
A child's chances of developing allergies or wheezing is related to how he or she grew at vital stages in the womb, according to scientists from the University of Southampton.
China's Ministry of Agriculture says scientists have confirmed an outbreak of bird flu has killed 1,000 domestic poultry in a village in China's northwest.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.
› Verified 4 days ago
| Entity Name | Chattanooga Hamilton County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154751931 PECOS PAC ID: 0547179731 Enrollment ID: O20040302001086 |
News Archive
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed a clay-based platform to deliver therapeutic proteins to the body to assist with the formation of blood vessels.
A child's chances of developing allergies or wheezing is related to how he or she grew at vital stages in the womb, according to scientists from the University of Southampton.
China's Ministry of Agriculture says scientists have confirmed an outbreak of bird flu has killed 1,000 domestic poultry in a village in China's northwest.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.
› Verified 4 days ago
| Entity Name | Erlanger Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477256303 PECOS PAC ID: 1153780226 Enrollment ID: O20230707000849 |
News Archive
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed a clay-based platform to deliver therapeutic proteins to the body to assist with the formation of blood vessels.
A child's chances of developing allergies or wheezing is related to how he or she grew at vital stages in the womb, according to scientists from the University of Southampton.
China's Ministry of Agriculture says scientists have confirmed an outbreak of bird flu has killed 1,000 domestic poultry in a village in China's northwest.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Eric Boehm Sr, MD 1010 E 3rd St Ste 202, Chattanooga, TN 37403-2174 Ph: (423) 265-2233 | Dr Peter Eric Boehm Sr, MD 1010 E 3rd St Ste 202, Chattanooga, TN 37403-2174 Ph: (423) 265-2233 |
News Archive
Formation of new blood vessels, a process also known as angiogenesis, is one of the major clinical challenges in wound healing and tissue implants. To address this issue, researchers from Texas A&M University have developed a clay-based platform to deliver therapeutic proteins to the body to assist with the formation of blood vessels.
A child's chances of developing allergies or wheezing is related to how he or she grew at vital stages in the womb, according to scientists from the University of Southampton.
China's Ministry of Agriculture says scientists have confirmed an outbreak of bird flu has killed 1,000 domestic poultry in a village in China's northwest.
The U.S. Food and Drug Administration today approved a new indication for Tasigna (nilotinib) for the treatment of a rare blood cancer when it is first diagnosed. The cancer, called Philadelphia chromosome positive chronic phase chronic myeloid leukemia (Ph+ CP-CML), is a slowly progressing blood and bone marrow disease linked to a genetic abnormality.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.
› Verified 4 days ago
Joseph Hardy Miller, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 E 3rd St, Suite 202, Chattanooga, TN 37403 Phone: 423-265-2233 Fax: 423-756-8265 | |
Ranjith Babu, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Glenwood Dr Ste E790, Chattanooga, TN 37404 Phone: 423-206-4140 | |
Dr. Timothy Alexander Strait, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1010 E 3rd St, Suite 202, Chattanooga, TN 37403 Phone: 423-265-2233 Fax: 423-756-8265 | |
Dr. Mayshan Ghiassi, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Glenwood Dr Ste E486, Chattanooga, TN 37404 Phone: 423-206-9480 Fax: 423-206-9481 | |
Dr. Michael Richard Gallagher, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 E 3rd St, Suite 202, Chattanooga, TN 37403 Phone: 423-265-2233 Fax: 423-756-8265 | |
Dr. Peter Eric Boehm Jr., MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 E 3rd St Ste 202, Chattanooga, TN 37403 Phone: 423-265-2233 Fax: 423-756-8265 | |
Prayash Gaurang Patel, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 E 3rd St, Suite 202, Chattanooga, TN 37403 Phone: 423-265-2233 Fax: 423-756-8265 |